General

Showing 1265–1280 of 1329 results

• 

  Article: Trastuzumab deruxtecan solidified as the preferred 2nd line treatment for patients with HER2-positive metastatic BC: updated results from DESTINY-Breast03

  €3.03 Add to cart
• 

  Article: Traveling the prostate cancer timeline in chase of treatment paradigms: Can we cure the incurable?

  €3.03 Add to cart
• 

  Article: Treat mTNBC with more support. Visit GileadPro.be.

  €3.03 Add to cart
• 

  Article: Treating upper digestive bleeding may cause multiple infectious complications in a cancer patient

  €3.03 Add to cart
• 

  Article: Treatment algorithm ER positive HER2 negative Advanced Breast Cancer

  €3.03 Add to cart
• 

  Article: Treatment of metastatic melanoma: an update on the Belgian situation

  €3.03 Add to cart
• 

  Article: Treatment of non-small cell lung carcinoma with gefitinib: a case report

  €3.03 Add to cart
• 

  Article: Treatment of poor-prognosis germ-cell tumours

  €3.03 Add to cart
• 

  Article: Treatment options in patients with early breast cancer and BRCA-mutations or family history of cancer

  €3.03 Add to cart
• 

  Article: Treatment sequencing in patients with advanced mutant melanoma

  €3.03 Add to cart
• 

  Article: Treatment-induced anaemia in solid tumours with emphasis on newer anti-cancer drugs

  €3.03 Add to cart
• 

  Article: Tribute to Uro-Oncology

  €3.03 Add to cart
• 

  Article: Triple-negative breast cancer: current treatment and future perspectives

  €3.03 Add to cart
• 

  Article: TRODELVY® (SACITUZUMAB GOVITECAN)

  €3.03 Add to cart
• 

  Article: TRODELVY® (SACITUZUMAB GOVITECAN)

  €3.03 Add to cart
• 

  Article: Trop-2 targeted therapy in breast cancer

  €3.03 Add to cart